TUCKER ASSET MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1870012
LITTLETON, CO
Position in VRTX
as of Dec 31, 2025
· filed Feb 5, 2026
Position Value
$4,080
+$1,664 QoQ
Shares Held
9
+50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025TUCKER ASSET MANAGEMENT LLC holds $69,678 across 13 Biotechnology names. VRTX ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
767 | $33,617 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
207 | $10,855 | |
| 3 | QNTM |
Quantum Biopharma Ltd.
|
1,114 | $8,132 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
1,442 | $5,897 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
9 | $4,080 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
57 | $3,836 | |
| 7 | ARGX |
Argenx SE
|
2 | $1,681 | |
| 8 | ABSI |
Absci Corp
|
200 | $698 |
All Filings in VRTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4,080 | 9 | Shares | Sole | 2026-02-05 | |
| 2024-12-31 | $2,416 | 6 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,790 | 6 | Shares | Sole | 2025-02-03 | |
| 2024-06-30 | $2,812 | 6 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,508 | 6 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||